Stem, Inc. (NYSE:STEM) Director Adam Daley Sells 75,000 Shares of Stock

Stem, Inc. (NYSE:STEMGet Rating) Director Adam Daley sold 75,000 shares of the company’s stock in a transaction that occurred on Thursday, November 17th. The shares were sold at an average price of $13.63, for a total value of $1,022,250.00. Following the completion of the transaction, the director now directly owns 171,251 shares of the company’s stock, valued at $2,334,151.13. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Stem Trading Down 1.5 %

NYSE STEM opened at $13.01 on Tuesday. The stock’s 50-day simple moving average is $13.54 and its two-hundred day simple moving average is $11.34. Stem, Inc. has a twelve month low of $5.72 and a twelve month high of $23.50. The company has a quick ratio of 2.11, a current ratio of 2.23 and a debt-to-equity ratio of 0.78. The company has a market capitalization of $2.01 billion, a price-to-earnings ratio of -16.06 and a beta of 2.09.

Stem (NYSE:STEMGet Rating) last released its quarterly earnings results on Thursday, November 3rd. The company reported ($0.22) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.07). Stem had a negative net margin of 47.19% and a negative return on equity of 21.30%. The firm had revenue of $99.50 million for the quarter, compared to analysts’ expectations of $89.81 million. Research analysts forecast that Stem, Inc. will post -0.75 EPS for the current fiscal year.

Analysts Set New Price Targets

STEM has been the subject of several research reports. Morgan Stanley increased their price objective on Stem from $20.00 to $21.00 and gave the company an “equal weight” rating in a report on Thursday, September 29th. Cowen reduced their price objective on Stem from $22.00 to $20.00 and set an “outperform” rating for the company in a report on Thursday, September 29th. Northland Securities assumed coverage on Stem in a report on Wednesday, September 7th. They set an “outperform” rating and a $24.00 price objective for the company. UBS Group assumed coverage on Stem in a research report on Tuesday, October 25th. They set a “buy” rating and a $19.00 target price on the stock. Finally, Guggenheim set a $17.00 target price on Stem in a research report on Thursday, September 29th. One research analyst has rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $21.30.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of STEM. Nisa Investment Advisors LLC grew its stake in shares of Stem by 232.3% during the second quarter. Nisa Investment Advisors LLC now owns 5,283 shares of the company’s stock valued at $38,000 after buying an additional 3,693 shares during the last quarter. Canada Pension Plan Investment Board bought a new position in shares of Stem during the third quarter valued at about $44,000. Zurcher Kantonalbank Zurich Cantonalbank bought a new position in shares of Stem during the second quarter valued at about $53,000. Point72 Hong Kong Ltd bought a new position in shares of Stem during the first quarter valued at about $67,000. Finally, Trexquant Investment LP bought a new position in shares of Stem during the second quarter valued at about $73,000. 52.42% of the stock is owned by institutional investors.

About Stem

(Get Rating)

Stem, Inc operates as a digitally connected and intelligent energy storage network provider in the United States and internationally. It offers energy storage systems sourced from original equipment manufacturers (OEMs). The company also provides Athena, an artificial intelligence platform, which offers battery hardware and software-enabled services to operate the energy storage systems.

Read More

Insider Buying and Selling by Quarter for Stem (NYSE:STEM)

Receive News & Ratings for Stem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stem and related companies with MarketBeat.com's FREE daily email newsletter.